General
Preferred name
TOLFENAMIC ACID
Synonyms
GEA 6414 ()
Tolfedine ()
Clotam ()
Clotam Rapid ()
NSC-757873 ()
N-(3-chloro-o-tolyl)anthranilic ()
Acido tolfenamico ()
Acide tolfenamique ()
Tolfenamic Acid-d4 ()
P&D ID
PD001455
CAS
13710-19-5
1246820-82-5
Tags
available
drug
First approval
1976
Drug Status
approved
investigational
Max Phase
2.0
Drug indication
rheumatic disease
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic and anti-inflammatory actions .
(GtoPdb)
DESCRIPTION
Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory and anti-cancer agent, selectively inhibits COX-2, with an IC50 of 13.49 ¦ÌM (3.53 ¦Ìg/mL) in LPS-treated (COX-2) canine DH82 monocyte/macrophage cells, but shows no effect on COX-1.
PRICE
29
DESCRIPTION
Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory drug (NSAID) used to treat migraine symptoms.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
24
AdooQ Bioactive Compound Library
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
42
Molecular Weight
261.06
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
4.09
TPSA
49.33
Fraction CSP3
0.07
Chiral centers
0.0
Largest ring
6.0
QED
0.87
QED
0.87
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
COX
COX-2
MOA
cyclooxygenase inhibitor, prostanoid receptor antagonist
Indication
migraine headache
Pathway
Immunology/Inflammation
Neuroscience
Source data

